Abbott India Recalls Penicillin Antibiotic Batches Due to Puffing Issues
Abbott india Recalls Penicillin Antibiotic Batches Due to Puffing Issues
Abbott india is recalling multiple batches of its Penicillin G-based antibiotic following reports of puffed strips. The company is voluntarily pulling batches of Pentids 800, Pentids 400, and Pentids 200 tablets from the market. These tablets, manufactured by Akums drugs & Pharmaceuticals Ltd—a newly listed contract manufacturer—are used to treat various bacterial infections, including those of the respiratory tract, skin, and sexually transmitted diseases like syphilis.
According to a letter from abbott india, accessed by News18, “Isolated complaints have been reported concerning puffed strips in Pentids 800, 400, and 200 tablets.” The company has initiated a voluntary Level II recall as a precautionary measure while investigating the issue with the manufacturer.
Abbott clarified that there have been no health-related complaints associated with the issue, and the problem does not affect any other abbott products. Alternatives are available. The company has instructed its partners to check their inventories for the affected batches, return the products, and ensure that recalled stocks are collected from stockists and retailers.
This recall follows previous actions by abbott, including voluntary recalls of its Digene Gel and a mislabelled batch of Thyronorm last year. In July, French pharmaceutical firm Sanofi also recalled its Allegra suspension syrup and Combiflam suspension from the indian market.
Abbott india is recalling multiple batches of its Penicillin G-based antibiotic following reports of puffed strips. The company is voluntarily pulling batches of Pentids 800, Pentids 400, and Pentids 200 tablets from the market. These tablets, manufactured by Akums drugs & Pharmaceuticals Ltd—a newly listed contract manufacturer—are used to treat various bacterial infections, including those of the respiratory tract, skin, and sexually transmitted diseases like syphilis.
According to a letter from abbott india, accessed by News18, “Isolated complaints have been reported concerning puffed strips in Pentids 800, 400, and 200 tablets.” The company has initiated a voluntary Level II recall as a precautionary measure while investigating the issue with the manufacturer.
Abbott clarified that there have been no health-related complaints associated with the issue, and the problem does not affect any other abbott products. Alternatives are available. The company has instructed its partners to check their inventories for the affected batches, return the products, and ensure that recalled stocks are collected from stockists and retailers.
This recall follows previous actions by abbott, including voluntary recalls of its Digene Gel and a mislabelled batch of Thyronorm last year. In July, French pharmaceutical firm Sanofi also recalled its Allegra suspension syrup and Combiflam suspension from the indian market.